Related Experiment Video
Updated: Jan 12, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Impact of heatwaves on glycemic control in adults with type 1 diabetes using hybrid closed-loop systems
Jesus Moreno-Fernandez1,2, Luz María López3, Esther Maqueda4
1Ciudad Real General University Hospital. Ciudad Real, Obispo Rafael Torija, St, Ciudad Real, 13005, Spain. jmorenof@sescam.jccm.es.
Abstract:
To evaluate the effect of the August´s 2023 heatwaves over glycemic control in adults with type 1 diabetes (T1D) treated with advance hybrid closed-loop systems (AHCL). Cross-sectional retrospective analysis of adult patients with T1D in Castilla-La Mancha (south-central Spanish region) using AHCL during the August´s 2023 heatwaves period. Primary outcome was change in time in range (TIR) 3.0-10 mmol/L (70-180 mg/dL) of interstitial glucose after the end of the heatwaves period. A total of 193 T1D patients were analyzed. TIR remained constant after the end of the heatwaves period (0.5% [95% CI -0.3, 1.3; P = 0.236]). No differences were observed among the rest of glycometric index. The percentage of patients meeting all the recommendations of the International Consensus of Time in Range was similar during the heatwaves period than after it ended (44.6% vs. 45.6%, P = 1.000). Finally, the percentage of time in automatization and daily insulin dose also stayed stable (0.5% [95% CI -1.4, 2.4; P = 0.601] and 0.0 UI/day [95% CI -1.0, 1.0; P = 0.981], respectively). Adults with T1D treated with AHCL maintained glycemic control during August´s 2023 heatwaves. These data raise the possibility that AHCL systems could help protect T1D patients from the effects of heatwaves on glycemic control.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...